SCHEMBL700792

SCHEMBL700792

COCC(=O)N1CCc2c([nH]c3ccccc23)C12CCC(C(c1ccc(Cl)cc1)N(C)C)CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.46
OGFRL1 Q5TC84 2/20 0.46
OPRL1 P41146 1/20 0.39
OPRD1 P41143 3/20 0.39
OPRK1 P41145 2/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
KMT2A Q03164 2/20 0.37
TRPA1 O75762 3/20 0.37
TRPV1 Q8NER1 3/20 0.37
POLB P06746 1/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PAX8 Q06710 1/20 0.35
ESR1 P03372 1/20 0.35
BCHE P06276 1/20 0.35
MEN1 O00255 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL699890 0.94 OPRM1 (0.50) OPRM1OGFRL1OPRL1OPRD1OPRK1
SCHEMBL699679 0.92 OPRM1 (0.44) OPRM1OGFRL1OPRL1OPRD1OPRK1
SCHEMBL699347 0.91 OPRM1 (0.47) OPRM1OGFRL1OPRL1KMT2ATRPA1
SCHEMBL700360 0.90 OPRM1 (0.44) OPRM1OGFRL1OPRL1KMT2APOLB
SCHEMBL700373 0.90 OPRM1 (0.46) OPRM1OGFRL1OPRL1OPRD1CHRNB4
SCHEMBL699295 0.90 OPRM1 (0.46) OPRM1OGFRL1OPRL1OPRD1OPRK1
SCHEMBL700530 0.89 OPRM1 (0.46) OPRM1OGFRL1OPRL1OPRD1CHRNB4
SCHEMBL700077 0.89 OPRM1 (0.42) OPRM1OGFRL1OPRL1KMT2ALMNA
SCHEMBL699379 0.88 LMNA (0.48) OPRM1OGFRL1OPRL1KMT2APOLB
SCHEMBL700318 0.88 OPRM1 (0.45) OPRM1OGFRL1OPRL1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124788-B2 Spirocyclic cyclohexane compounds with analgesic activity GRUENENTHAL GMBH (DE) 2012-02-28 US claimed
EP-2010531-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES WITH ANALGESIC PROPERTIES GRUENENTHAL GMBH (DE) 2011-08-17 EP claimed
US-20090111842-A1 SPIROCYCLIC CYCLOHEXANE COMPOUNDS WITH ANALGESIC ACTIVITY GRUENENTHAL GMBH (DE) 2009-04-30 US claimed
US-8124788-B2 Spirocyclic cyclohexane compounds with analgesic activity GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
EP-2010531-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES WITH ANALGESIC PROPERTIES GRUENENTHAL GMBH (DE) 2011-08-17 EP disclosed
US-20090111842-A1 SPIROCYCLIC CYCLOHEXANE COMPOUNDS WITH ANALGESIC ACTIVITY GRUENENTHAL GMBH (DE) 2009-04-30 US disclosed
EP-2010531-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVE WITH ANALGESIC PROPERTIES Grünenthal GmbH (DE) 2009-01-07 EP disclosed
WO-2007124903-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVE WITH ANALGESIC PROPERTIES Grünenthal GmbH (DE) 2007-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111842-A1 SPIROCYCLIC CYCLOHEXANE COMPOUNDS WITH ANALGESIC ACTIVITY OPRK1, OPRL1, OPRD1 OPRM1 9/4885OGFRL1 163/4885OPRL1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.